Skip to main content

J&J suspends COVID vaccine sales guidance, citing supply surplus

By The Wall Street Journal  
   April 19, 2022

In its consumer business, sales were hampered by supply constraints that mostly held back the company's skin-care and beauty-product lines.

Full story


Get the latest on healthcare leadership in your inbox.